darolutamide
bayer
['nubeqa', 'prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
patients with non-metastatic castration-resistant prostate cancer were less likely to experience disease progression on nubeqa. #gu23 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.